 | A major contributor to this article appears to have a close connection with its subject. (January 2022) |
Yossi Gross יוסי גרוס | |
|---|---|
 Yossi Gross | |
| Born | February 5, 1947 |
| Occupation | Entrepreneur |
| Children | Amir Gross, CEO, Valtech Inbal Gross, Interior design |
| Website | Rainbow Medical web site |
Yossi Gross (Hebrew: יוסי גרוס; born February 5, 1947) is an Israeli inventor and entrepreneur.[1] He is a founding partner of Rainbow Medical, an operational investment company, established to launch companies based on the technological ideas and inventions of Gross.[2] Yossi Gross is the founder of multiple medical device companies based on his various inventions in active implantables, neurostimulation, signal processing, nanotechnology, and drug delivery. Gross's various companies have developed or are currently developing treatments for diabetes, gastroenterology, stroke, ophthalmology, asthma, congestive heart failure, and urology.[3] Gross has over 800 filed patents.[4][5] Companies based on his inventions collectively garnered over $1B dollars in acquisitions.[6][7]
- ^ "Abigail K. Leichman "I thought I could do it better",Israel21c, August 10, 2009".
- ^ "Jacques Ungar, "Rainbow Medical, A die hard Optimist",Tachles, July 10, 2009".
- ^ "Mary Stuart, "The Creative Mind of Yossi Gross, Medical Device Inventor," Start-Up 10/2006, Art# 2006900195" (PDF).
- ^ "United States Patent and Trademark Office".
- ^ "Jonathan Matsey, "Rainbow Medical Hunts $10M To Launch More Med Device Cos.," Dow Jones Venture Wire, June 10, 2009".
- ^ Press, Viva Sarah (2016-11-29). "Edwards Lifesciences to acquire Valtech Cardio for up to $690 million". ISRAEL21c. Retrieved 2023-08-17.
- ^ Devarasetti, Hasini (2021-12-08). "Venus Medtech to acquire Cardiovalve for $300m". Medical Device Network. Retrieved 2023-08-17.